LUCIA FAJARDO: Open Payments
NPI 1255864849 · SANTEE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$281 in 17 payments from 4 companies in 2025. Trend: 2023 $202 · 2024 $274 · 2025 $281
Food & beverage: $281
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $180 |
| Lilly USA, LLC | 3 | $57 |
| GlaxoSmithKline, LLC. | 1 | $29 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: Ozempic, MOUNJARO, Saxenda, Wegovy, TRELEGY ELLIPTA, FARXIGA.
Industry payments across CA — which companies pay providers there.
